Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Phreesia stock

Learn how to easily invest in Phreesia stock.

Phreesia is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 1,701 staff and has a trailing 12-month revenue of around $262.3 million.

How to buy Phreesia stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – PHR. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Phreesia stock price (NYSE: PHR)

Use our graph to track the performance of PHR stocks over time.

Phreesia shares at a glance

Information last updated 2023-02-02.
Latest market close$37.22
52-week range$13.19 - $38.13
50-day moving average $31.77
200-day moving average $25.55
Wall St. target price$37.57
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.08

Buy Phreesia stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Phreesia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Phreesia price performance over time

Historical closes compared with the close of $37.22 from 2023-02-01

1 week (2023-01-25) 6.49%
1 month (2022-12-30) 15.02%
3 months (2022-10-29) N/A
6 months (2022-08-02) 50.69%
1 year (2022-02-02) 20.49%
2 years (2021-02-02) -46.01%
3 years (2020-01-31) 20.06%
5 years (2018-01-29) N/A

Phreesia financials

Revenue TTM $262.3 million
Gross profit TTM $131.8 million
Return on assets TTM -24.71%
Return on equity TTM -47.43%
Profit margin -70.36%
Book value $6.08
Market capitalisation $2 billion

TTM: trailing 12 months

Phreesia share dividends

We're not expecting Phreesia to pay a dividend over the next 12 months.

Phreesia share price volatility

Over the last 12 months, Phreesia's shares have ranged in value from as little as $13.19 up to $38.13. A popular way to gauge a stock's volatility is its "beta".

PHR.US volatility(beta: 0.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Phreesia's is 0.6018. This would suggest that Phreesia's shares are less volatile than average (for this exchange).

Phreesia overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

Frequently asked questions

What percentage of Phreesia is owned by insiders or institutions?
Currently 3.994% of Phreesia shares are held by insiders and 95.149% by institutions.
How many people work for Phreesia?
Latest data suggests 1,701 work at Phreesia.
When does the fiscal year end for Phreesia?
Phreesia's fiscal year ends in January.
Where is Phreesia based?
Phreesia's address is: 434 Fayetteville Street, Raleigh, NC, United States, 27601
What is Phreesia's ISIN number?
Phreesia's international securities identification number is: US71944F1066
What is Phreesia's CUSIP number?
Phreesia's Committee on Uniform Securities Identification Procedures number is: 71944F106

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site